Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up | Zendy

Niraj Varma | Zendy; Andrew E. Epstein | Zendy; Anand Irimpen | Zendy; Robert A. Schweikert | Zendy; Charles J. Love | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up

Author(s) -

Niraj Varma,

Andrew E. Epstein,

Anand Irimpen,

Robert A. Schweikert,

Charles J. Love

Publication year - 2010

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.110.937409

Subject(s) - medicine , implantable cardioverter defibrillator , ejection fraction , coronary artery disease , incidence (geometry) , randomized controlled trial , surgery , emergency medicine , heart failure , physics , optics

Monitoring implantable cardiac device function and patient condition is important. The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) trial tested the hypothesis that remote home monitoring with automatic daily surveillance (HM) is safe and effective for implantable cardioverter-defibrillator follow-up for 1 year and enables rapid physician evaluation of significant events.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research